| Deacon Vice, DO | |
|
4200 S Douglas Ave, Suite 306, Oklahoma City, OK 73109-3223 | |
| (405) 636-7709 | |
| Not Available |
| Full Name | Deacon Vice |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 11 Years |
| Location | 4200 S Douglas Ave, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073934352 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 5644 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lifeline Hospice, Inc. | Chickasha, OK | Hospice |
| Grady Memorial Hospital | Chickasha, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Grady Memorial Hospital | 0648175778 | 36 |
News Archive
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, and CareTrends Systems, a leading vital sign integration and intelligence software company, today announced a strategic partnership to help deliver advanced patient care and decrease costs for hospitals across North America.
Scientists have developed a lung-on-chip model to study how the body responds to early tuberculosis (TB) infection, according to findings published today in eLife.
Our brain cells control every aspect of our lives - from the movements we make to the memories we form. But capturing the activity of neurons in the form of electric impulses isn't easy.
The rapidly growing polio outbreak in Tajikistan raises serious concerns that the disease could spread to other regions in the world, states an editorial http://www.cmaj.ca/cgi/doi/10.1503/cmaj.100831 in CMAJ. It is imperative that health agencies attempt to limit further spread by ensuring high vaccination rates.
Silence Therapeutics plc, a leading global RNA interference (RNAi) therapeutics company, and InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA-based therapeutics for cancer, today announce that they have entered into an agreement to develop novel microRNA therapeutics for the treatment of cancer.
› Verified 9 days ago
| Entity Name | Grady Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750370268 PECOS PAC ID: 0648175778 Enrollment ID: O20031203000193 |
News Archive
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, and CareTrends Systems, a leading vital sign integration and intelligence software company, today announced a strategic partnership to help deliver advanced patient care and decrease costs for hospitals across North America.
Scientists have developed a lung-on-chip model to study how the body responds to early tuberculosis (TB) infection, according to findings published today in eLife.
Our brain cells control every aspect of our lives - from the movements we make to the memories we form. But capturing the activity of neurons in the form of electric impulses isn't easy.
The rapidly growing polio outbreak in Tajikistan raises serious concerns that the disease could spread to other regions in the world, states an editorial http://www.cmaj.ca/cgi/doi/10.1503/cmaj.100831 in CMAJ. It is imperative that health agencies attempt to limit further spread by ensuring high vaccination rates.
Silence Therapeutics plc, a leading global RNA interference (RNAi) therapeutics company, and InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA-based therapeutics for cancer, today announce that they have entered into an agreement to develop novel microRNA therapeutics for the treatment of cancer.
› Verified 9 days ago
| Entity Name | Carnegie Tri-county Municipal Hospital Management Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275657017 PECOS PAC ID: 6800835935 Enrollment ID: O20050429000480 |
News Archive
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, and CareTrends Systems, a leading vital sign integration and intelligence software company, today announced a strategic partnership to help deliver advanced patient care and decrease costs for hospitals across North America.
Scientists have developed a lung-on-chip model to study how the body responds to early tuberculosis (TB) infection, according to findings published today in eLife.
Our brain cells control every aspect of our lives - from the movements we make to the memories we form. But capturing the activity of neurons in the form of electric impulses isn't easy.
The rapidly growing polio outbreak in Tajikistan raises serious concerns that the disease could spread to other regions in the world, states an editorial http://www.cmaj.ca/cgi/doi/10.1503/cmaj.100831 in CMAJ. It is imperative that health agencies attempt to limit further spread by ensuring high vaccination rates.
Silence Therapeutics plc, a leading global RNA interference (RNAi) therapeutics company, and InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA-based therapeutics for cancer, today announce that they have entered into an agreement to develop novel microRNA therapeutics for the treatment of cancer.
› Verified 9 days ago
| Entity Name | Hospital Care Consultants Region Ii Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558491449 PECOS PAC ID: 8820197064 Enrollment ID: O20070727000300 |
News Archive
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, and CareTrends Systems, a leading vital sign integration and intelligence software company, today announced a strategic partnership to help deliver advanced patient care and decrease costs for hospitals across North America.
Scientists have developed a lung-on-chip model to study how the body responds to early tuberculosis (TB) infection, according to findings published today in eLife.
Our brain cells control every aspect of our lives - from the movements we make to the memories we form. But capturing the activity of neurons in the form of electric impulses isn't easy.
The rapidly growing polio outbreak in Tajikistan raises serious concerns that the disease could spread to other regions in the world, states an editorial http://www.cmaj.ca/cgi/doi/10.1503/cmaj.100831 in CMAJ. It is imperative that health agencies attempt to limit further spread by ensuring high vaccination rates.
Silence Therapeutics plc, a leading global RNA interference (RNAi) therapeutics company, and InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA-based therapeutics for cancer, today announce that they have entered into an agreement to develop novel microRNA therapeutics for the treatment of cancer.
› Verified 9 days ago
| Entity Name | Emergency Services Of Oklahoma Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215249891 PECOS PAC ID: 8123209012 Enrollment ID: O20110225000085 |
News Archive
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, and CareTrends Systems, a leading vital sign integration and intelligence software company, today announced a strategic partnership to help deliver advanced patient care and decrease costs for hospitals across North America.
Scientists have developed a lung-on-chip model to study how the body responds to early tuberculosis (TB) infection, according to findings published today in eLife.
Our brain cells control every aspect of our lives - from the movements we make to the memories we form. But capturing the activity of neurons in the form of electric impulses isn't easy.
The rapidly growing polio outbreak in Tajikistan raises serious concerns that the disease could spread to other regions in the world, states an editorial http://www.cmaj.ca/cgi/doi/10.1503/cmaj.100831 in CMAJ. It is imperative that health agencies attempt to limit further spread by ensuring high vaccination rates.
Silence Therapeutics plc, a leading global RNA interference (RNAi) therapeutics company, and InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA-based therapeutics for cancer, today announce that they have entered into an agreement to develop novel microRNA therapeutics for the treatment of cancer.
› Verified 9 days ago
| Entity Name | South Central Emergency Services, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558663724 PECOS PAC ID: 8224212949 Enrollment ID: O20110405000201 |
News Archive
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, and CareTrends Systems, a leading vital sign integration and intelligence software company, today announced a strategic partnership to help deliver advanced patient care and decrease costs for hospitals across North America.
Scientists have developed a lung-on-chip model to study how the body responds to early tuberculosis (TB) infection, according to findings published today in eLife.
Our brain cells control every aspect of our lives - from the movements we make to the memories we form. But capturing the activity of neurons in the form of electric impulses isn't easy.
The rapidly growing polio outbreak in Tajikistan raises serious concerns that the disease could spread to other regions in the world, states an editorial http://www.cmaj.ca/cgi/doi/10.1503/cmaj.100831 in CMAJ. It is imperative that health agencies attempt to limit further spread by ensuring high vaccination rates.
Silence Therapeutics plc, a leading global RNA interference (RNAi) therapeutics company, and InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA-based therapeutics for cancer, today announce that they have entered into an agreement to develop novel microRNA therapeutics for the treatment of cancer.
› Verified 9 days ago
| Entity Name | Oklahoma Emergency Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114239795 PECOS PAC ID: 3678757010 Enrollment ID: O20110411000211 |
News Archive
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, and CareTrends Systems, a leading vital sign integration and intelligence software company, today announced a strategic partnership to help deliver advanced patient care and decrease costs for hospitals across North America.
Scientists have developed a lung-on-chip model to study how the body responds to early tuberculosis (TB) infection, according to findings published today in eLife.
Our brain cells control every aspect of our lives - from the movements we make to the memories we form. But capturing the activity of neurons in the form of electric impulses isn't easy.
The rapidly growing polio outbreak in Tajikistan raises serious concerns that the disease could spread to other regions in the world, states an editorial http://www.cmaj.ca/cgi/doi/10.1503/cmaj.100831 in CMAJ. It is imperative that health agencies attempt to limit further spread by ensuring high vaccination rates.
Silence Therapeutics plc, a leading global RNA interference (RNAi) therapeutics company, and InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA-based therapeutics for cancer, today announce that they have entered into an agreement to develop novel microRNA therapeutics for the treatment of cancer.
› Verified 9 days ago
| Entity Name | Emergency Physicians Of Mid-america Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063825297 PECOS PAC ID: 2062638661 Enrollment ID: O20140716001692 |
News Archive
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, and CareTrends Systems, a leading vital sign integration and intelligence software company, today announced a strategic partnership to help deliver advanced patient care and decrease costs for hospitals across North America.
Scientists have developed a lung-on-chip model to study how the body responds to early tuberculosis (TB) infection, according to findings published today in eLife.
Our brain cells control every aspect of our lives - from the movements we make to the memories we form. But capturing the activity of neurons in the form of electric impulses isn't easy.
The rapidly growing polio outbreak in Tajikistan raises serious concerns that the disease could spread to other regions in the world, states an editorial http://www.cmaj.ca/cgi/doi/10.1503/cmaj.100831 in CMAJ. It is imperative that health agencies attempt to limit further spread by ensuring high vaccination rates.
Silence Therapeutics plc, a leading global RNA interference (RNAi) therapeutics company, and InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA-based therapeutics for cancer, today announce that they have entered into an agreement to develop novel microRNA therapeutics for the treatment of cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Deacon Vice, DO 4200 S. Douglas, Suite 306, Oklahoma Ciry, OK 73109 Ph: () - | Deacon Vice, DO 4200 S Douglas Ave, Suite 306, Oklahoma City, OK 73109-3223 Ph: (405) 636-7709 |
News Archive
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, and CareTrends Systems, a leading vital sign integration and intelligence software company, today announced a strategic partnership to help deliver advanced patient care and decrease costs for hospitals across North America.
Scientists have developed a lung-on-chip model to study how the body responds to early tuberculosis (TB) infection, according to findings published today in eLife.
Our brain cells control every aspect of our lives - from the movements we make to the memories we form. But capturing the activity of neurons in the form of electric impulses isn't easy.
The rapidly growing polio outbreak in Tajikistan raises serious concerns that the disease could spread to other regions in the world, states an editorial http://www.cmaj.ca/cgi/doi/10.1503/cmaj.100831 in CMAJ. It is imperative that health agencies attempt to limit further spread by ensuring high vaccination rates.
Silence Therapeutics plc, a leading global RNA interference (RNAi) therapeutics company, and InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA-based therapeutics for cancer, today announce that they have entered into an agreement to develop novel microRNA therapeutics for the treatment of cancer.
› Verified 9 days ago
Dr. Hunter Dale Cook, D.O Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4401 S Western Ave, Oklahoma City, OK 73109 Phone: 405-636-7709 | |
Alejandro Anzaldua, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 900 Ne 10th St, Fmc 2102, Oklahoma City, OK 73104 Phone: 405-271-2230 | |
Dr. Diana Dee Mills-maloney, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 10312 Creek Meadow Dr, Oklahoma City, OK 73151 Phone: 405-771-3577 | |
Dr. David Brennan, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4401 S Western Ave, Oklahoma City, OK 73109 Phone: 405-636-7000 | |
Aaron Daniel Jones, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4401 S Western Ave, Oklahoma City, OK 73109 Phone: 405-636-7000 | |
Dr. David M. Abercrombie, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1624 Grey Fox Run, Oklahoma City, OK 73131 Phone: 405-478-3969 Fax: 405-478-3815 | |
Dr. Amy L. Sparkman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 940 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-271-2429 |